Insilico Medicine reports preliminary data from Phase IIa IPF treatment trial
Insilico Medicine has announced positive preliminary results from its Phase IIa clinical trial of ISM001-055, a small molecule drug designed …
Post
-
-
Carematrix launches blinded remote monitoring tech for clinical trials
US-based Carematrix has launched a blinded blood pressure monitor and scale designed to remotely monitor patients’ vitals in blinded clinical …
-
Roche reports positive data from Phase III influenza treatment trial
Roche has announced positive topline data from the Phase III CENTERSTONE clinical trial of Xofluza (baloxavir marboxil), an antiviral treatment …
-
Starton successfully delivers cancer drug using on-body injector
Starton Therapeutics has successfully demonstrated the use of BD’s on-body injector technology to deliver its low-dose lenalidomide formulation called STAR-LLD. An …
-
Mpox: Three ongoing vaccine trials to watch
In August 2024, the World Health Organization (WHO) declared mpox a public health emergency of international concern (PHEIC), two years …
-
Satellos Bioscience doses first subject in Phase I trial of SAT-3247
Satellos Bioscience has dosed the first subject in a Phase I clinical trial of SAT-3247, a potential treatment for Duchenne …
-
Brenus Pharma secures funding to advance cancer vaccine trials
Brenus Pharma has completed a Series A funding round, securing $25m to propel the clinical trials of its precision cancer …
-
“Leave politics out of healthcare” – controversy swirls around BIOSECURE Act
Members of the biotech industry have voiced concerns about the impact of the BIOSECURE Act, after the bill passed through …
-
Spread of EEE virus causes concern in northeastern US
The US Centers for Disease Control and Prevention reports that as of 10 September 2024, there have been eight cases …
-
Ossium treats first leukaemia patient in cryopreserved bone marrow trial
US bioengineering company Ossium Health has treated its first leukaemia patient with cryopreserved organ donor-derived bone marrow as part of …
-
Demystifying the role of the QP in the clinical trial supply chain
“We don’t want to reject a batch; we understand the role we play in these supply chains and the development …
-
Implantica’s anti-reflux device shows positive two-year results
Implantica has unveiled positive two-year results for its RefluxStop device, an implant designed to manage gastro-oesophageal reflux disease (GORD). Results from …
-
Aclaris doses first subject in Phase IIa atopic dermatitis treatment trial
Aclaris Therapeutics has dosed the first subject in the Phase IIa clinical trial of ATI-2138 to treat moderate to severe …
-
FDA lifts partial clinical hold on Vigil Neuroscience’s Phase I VG-3927 trial
The US Food and Drug Administration (FDA) has lifted the partial clinical hold on Vigil Neuroscience’s Phase I trial of …
-
Medtronic teases positive data adaptive deep brain stimulation trial
Medtronic has published preliminary data from a study of its adaptive deep brain stimulation (aDBS) device, Percept PC neurostimulator, in …
